Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Stock Price Passes Above 200 Day Moving Average - Here's Why

Eurofins Scient logo with Medical background

Shares of Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $58.20 and traded as high as $71.85. Eurofins Scient shares last traded at $71.53, with a volume of 715 shares changing hands.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on ERFSF shares. HSBC lowered Eurofins Scient to a "hold" rating in a research note on Friday, April 25th. Hsbc Global Res lowered Eurofins Scient from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 25th. Five research analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold".

Read Our Latest Stock Report on ERFSF

Eurofins Scient Stock Performance

The company has a quick ratio of 1.09, a current ratio of 1.16 and a debt-to-equity ratio of 0.58. The business has a fifty day moving average price of $67.50 and a 200 day moving average price of $58.35.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

See Also

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines